Position in ALEC
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$43,058
+$8,138 QoQ
Shares Held
20,027
-10.5% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ALEC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BNP PARIBAS ARBITRAGE, SA holds $2,946,405,239 across 415 Biotechnology names. ALEC ranks #260 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
448,371 | $346,429,369 | |
| 2 | MRNA |
Moderna, Inc.
|
4,317,219 | $219,314,725 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
415,625 | $185,593,187 | |
| 4 | BNTX |
BioNTech SE
|
1,651,789 | $146,811,006 | |
| 5 | ARGX |
Argenx SE
|
177,836 | $129,864,739 | |
| 6 | INSM |
INSMED Inc
|
604,600 | $98,864,192 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,307,176 | $97,070,889 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
280,965 | $92,962,889 |
All Filings in ALEC
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $43,058 | 20,027 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $34,920 | 22,385 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $54,076 | 18,269 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $16,287 | 11,634 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $193,490 | 157,309 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $312,963 | 165,589 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $93,759 | 20,120 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $306,867 | 67,592 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $264,434 | 43,926 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $757,740 | 94,955 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $522,728 | 80,668 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $311,912 | 51,899 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $758,986 | 122,615 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,008,543 | 109,268 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $729,810 | 77,147 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $143,032 | 14,078 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $145,749 | 10,228 | Shares | Defined | 2022-05-18 | |
| 2021-12-31 | $251,042 | 12,157 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $642,656 | 28,162 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $412,163 | 19,787 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $468,295 | 23,252 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $341,756 | 22,588 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $310,466 | 29,470 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $560,580 | 22,937 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $384,004 | 15,914 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||